Edition:
United States

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

22.68USD
14 Dec 2018
Change (% chg)

$-0.71 (-3.04%)
Prev Close
$23.39
Open
$23.22
Day's High
$23.49
Day's Low
$21.75
Volume
14,581
Avg. Vol
28,328
52-wk High
$25.57
52-wk Low
$7.74

Chart for

About

KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The Company has developed a portfolio of small molecule plasma kallikrein... (more)

Overall

Beta: --
Market Cap(Mil.): $70.42
Shares Outstanding(Mil.): 9.71
Dividend: --
Yield (%): --

Financials

  KALV.OQ Industry Sector
P/E (TTM): -- 31.13 34.39
EPS (TTM): -3.21 -- --
ROI: -60.80 15.55 14.96
ROE: -61.05 16.92 16.52

Earnings vs. Estimates